Your browser doesn't support javascript.
loading
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.
Ma, Shoubao; Sun, Baofa; Duan, Songqi; Han, Jingjing; Barr, Tasha; Zhang, Jianying; Bissonnette, Marc B; Kortylewski, Marcin; He, Chuan; Chen, Jianjun; Caligiuri, Michael A; Yu, Jianhua.
Afiliación
  • Ma S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.
  • Sun B; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA.
  • Duan S; College of Life Sciences, Nankai University, Tianjin, China.
  • Han J; College of Food Science, Sichuan Agricultural University, Ya'an, China.
  • Barr T; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.
  • Zhang J; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA.
  • Bissonnette MB; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.
  • Kortylewski M; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA.
  • He C; Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Los Angeles, CA, USA.
  • Chen J; Department of Medicine, The University of Chicago, Chicago, IL, USA.
  • Caligiuri MA; Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Los Angeles, CA, USA.
  • Yu J; Departments of Chemistry and Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.
Nat Immunol ; 24(2): 255-266, 2023 02.
Article en En | MEDLINE | ID: mdl-36658237

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos